Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours
|
By LabMedica International staff writers Posted on 19 Mar 2021 |

Illustration
Scientists have developed direct rapid cost-effective COVID-19 tests that successfully identify the UK or South African variant of the SARS-CoV-2 virus.
The tests developed by scientists at the Ben-Gurion University of the Negev (Be'er Sheva, Israel) reduce the time needed to determine whether an infection is caused by a variant from days to hours. Comparatively, current tests for the UK and South African coronavirus variants are either expensive, time-consuming, or indirect. The current standard for coronavirus variants testing is sequencing the entire virus genome, which is expensive and time-consuming.
The new recently-developed RT-qPCR rapid tests are based on the gene deletion that differentiates the variants from the original SARS-CoV-2 strain. The scientists held trials of their tests on sewage samples from Beer-Sheva and successfully detected the UK variant but not the South African variant, which corresponded to the variants prevalent in Israel at the time.
"My lab has been working hard throughout this pandemic to provide early warning and detection tools. Our detection system of corona in wastewater successfully completed a pilot program in 14 cities around Israel," said Prof. Ariel Kushmaro who supervised the development of the tests. "We continue to refine our research in service to humankind."
Related Links:
Ben-Gurion University of the Negev
The tests developed by scientists at the Ben-Gurion University of the Negev (Be'er Sheva, Israel) reduce the time needed to determine whether an infection is caused by a variant from days to hours. Comparatively, current tests for the UK and South African coronavirus variants are either expensive, time-consuming, or indirect. The current standard for coronavirus variants testing is sequencing the entire virus genome, which is expensive and time-consuming.
The new recently-developed RT-qPCR rapid tests are based on the gene deletion that differentiates the variants from the original SARS-CoV-2 strain. The scientists held trials of their tests on sewage samples from Beer-Sheva and successfully detected the UK variant but not the South African variant, which corresponded to the variants prevalent in Israel at the time.
"My lab has been working hard throughout this pandemic to provide early warning and detection tools. Our detection system of corona in wastewater successfully completed a pilot program in 14 cities around Israel," said Prof. Ariel Kushmaro who supervised the development of the tests. "We continue to refine our research in service to humankind."
Related Links:
Ben-Gurion University of the Negev
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read moreMolecular Diagnostics
view channel
ctDNA Blood Test Could Help Guide Radiotherapy in Patients with Limited Metastases
Selecting the right therapy for patients whose solid tumors have begun to spread remains a major clinical challenge. Clinicians often count metastatic lesions on X-ray, computed tomography (CT), or magnetic... Read more
FDA-Approved MRD Blood Test Guides Adjuvant Bladder Cancer Therapy
Muscle-invasive bladder cancer (MIBC) carries a substantial risk of recurrence after radical cystectomy, and selecting which patients require adjuvant therapy remains challenging. Approximately 30,000... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read more
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more









